Ducharme is a contributor to TIME. Abstract image of end to corona virus emergency Ducharme is a contributor to TIME. As a health journalist, I've written the phrase “the COVID-19 pandemic” more times ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

In a recent study published in the journal Emerging Infectious Diseases, researchers used data from a large case-cohort clinical trial (1,120 cases, 1,126 controls) to simulate 24 separate scenarios ...

Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

As much as we’d like to think that COVID-19 is behind us, the virus isn’t going anywhere. Health officials continue to recommend that people get vaccinated for both COVID-19 and influenza every year ...

Este artículo estará disponible en español en El Tiempo Latino. Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and ...

Healthy Americans under 65 who want an annual COVID vaccine will be out of luck under a new Food and Drug Administration policy unveiled Tuesday. Under the plan, the FDA will allow seniors and other ...

Thailand urges calm over Singapore's Covid-19 spike, stating the dominant NB.1.8.1 variant is already circulating ...